BWA
CORT icon

BDO Wealth Advisors’s Corcept Therapeutics CORT Stock Holding History

BDO Wealth Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-35
Closed -$1K – 1038
2022
Q2 		$1K Hold
35
– – ﹤0.01% 951
2022
Q1 		$1K Hold
35
– – ﹤0.01% 972
2021
Q4 		$1K Hold
35
– – ﹤0.01% 991
2021
Q3 		$1K Hold
35
– – ﹤0.01% 985
2021
Q2 		$1K Hold
35
– – ﹤0.01% 1033
2021
Q1 		$1K Hold
35
– – ﹤0.01% 1049
2020
Q4 		$1K Hold
35
– – ﹤0.01% 828
2020
Q3 		$1K Buy
+35
New +$558 ﹤0.01% 752

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BDO Wealth Advisors's CORT Position: Q3 2022 in Review

BDO Wealth Advisors sold out of Corcept Therapeutics (CORT) in Q3 2022, closing a stake of 35 shares — an estimated $1K sold.

BDO Wealth Advisors first reported a position in CORT in Q3 2020 and held it in 8 quarters. The position peaked at $1K in Q2 2022. 238 funds tracked by Wall St. Rank hold CORT as of Q3 2022.

  • BDO Wealth Advisors reported no remaining Corcept Therapeutics position as of Q3 2022 after selling out during the quarter.
  • BDO Wealth Advisors sold 35 Corcept Therapeutics shares in Q3 2022, an estimated $1K.
  • BDO Wealth Advisors first reported a position in Corcept Therapeutics in Q3 2020 and held it in 8 quarters.
  • BDO Wealth Advisors's Corcept Therapeutics position peaked at $1K in Q2 2022.
  • 238 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2022.

Based on BDO Wealth Advisors's 13F filing for Q3 2022, filed 1 Nov 2022.